Patent · US Active

HER3 inhibitor for modulating radiosensitivity

US10357566B2 · kind B2 · utility

1Cited by

4References

21Claims

0Family size

Assignee

DAIICHI SANKYO EUROPE GMBH · DE

Inventors

Deric L. Wheeler · Madison, US
Thore Hettmann · Birkenfeld, DE

Key dates

Filing date	Feb 22, 2013
Grant date	Jul 23, 2019
Priority date	—
Expiry date	Feb 22, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/73
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the use of an inhibitor of HER-3 for the treatment of a hyperproliferative disease in combination with radiation treatment.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.